Royal Biologics launches new bone graft substitute

Royal Biologics launched its Bio-Reign 3D bone graft substitute, the company said May 23.

Advertisement

Bio-Reign 3D is a natural hyper-crosslinked carbohydrate polymer bone graft substitute, according to a news release. It is radiolucent when implanted and becomes radioplaque as the bone heals. 

Bio-Reign 3D also has a degredation profile that matches bone formation and can be sutured in place to prevent migration.

Royal Biologics also announced a licensing agreement of Molecular Matrix’s Osteo-P BGS technology.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.